Inflammatory Bowel Disease

Mirikizumab, a monoclonal antibody poised to become first-in-class treatment for ulcerative colitis, has the potential to transform treatment paradigms — if it can distinguish itself in an already saturated and competitive market.

Researchers at University of Miami Miller School of Medicine were awarded a $2.9 million grant by the NIH to study the genetic data of more than 3,000 Hispanic individuals to better understand inflammatory bowel disease in that population.

While acne was associated with incidence of inflammatory bowel disease, two drug classes used to treat acne had no such association, according to a study.

In this Healio video exclusive, Crohn’s patient advocate Madhura Balasubramaniam discusses how care interventions are often unaffordable and unattainable for the average South Asian patient with inflammatory bowel disease.

Last week, Healio provided coverage of the Crohn’s and Colitis Congress.

In this Healio video, Marla Dubinsky, MD, chief of pediatric gastroenterology at Mount Sinai Kravis Children’s Hospital, discusses how ulcerative colitis impacts pregnancy.

In this Healio video, Marla Dubinsky, MD, chief of pediatric gastroenterology at Mount Sinai Kravis Children’s Hospital, discusses recent approvals for ulcerative colitis.

In this Healio video, Marla Dubinsky, MD, chief of pediatric gastroenterology at Mount Sinai Kravis Children’s Hospital, discusses recent COVID-19 has impacted ulcerative colitis care.

In this Healio video, Marla Dubinsky, MD, chief of pediatric gastroenterology at Mount Sinai Kravis Children’s Hospital, discusses the unmet needs of patients with ulcerative colitis.

In this Healio video, Marla Dubinsky, MD, chief of pediatric gastroenterology at Mount Sinai Kravis Children’s Hospital, discusses the long-term effects of ulcerative colitis treatment for younger patients.